Log In
Print
BCIQ
Print
Print this Print this
 

AMG 181

  Manage Alerts
Collapse Summary General Information
Company Amgen Inc.
DescriptionHuman mAb to alpha4/beta7 that blocks binding of mucosal vascular addressin cell adhesion molecule 1 (MAdCAM-1)
Molecular Target Mucosal vascular addressin cell adhesion molecule 1 (MAdCAM-1)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today